ISSN 2639-9431
Vol. 9, Issue 1, 2026February 19, 2026 EDT
Nanoparticles for brain disease: translational failures, blood-brain barrier heterogeneity, and precision design constraints
Nanoparticles for brain disease: translational failures, blood-brain barrier heterogeneity, and precision design constraints
Arun Kumar Nirmal, Btech, Mtech (candidate), Haripriya Dayalan, Ph.D, Rohith S, Btech, Mtech (candidate), Gayathri Ayyar, Btech (candidate),
Articles in Vol. 9, Issue 1, 2026
Vol. 9, Issue 1, 2026
- Evaluating Indigenous Lytic Bacteriophages for Activity Against Multi-Resistant EnterobacteriaceaeEbele B. OnuigboStephen Chijioke EmenchetaChinonye EneovoEmmanuel ArinzeMaria NgwuMarie U. E. DibuaAnthony A. Attama
- Irisin-loaded Porous Silica Nanoparticles Enhance Bone Healing in High Cholesterol Diet-induced Medaka Fish ModelPrashant SadanandanSilja KrishnanManzoor KoyakuttyManitha Nair
- Nanoparticles for brain disease: translational failures, blood-brain barrier heterogeneity, and precision design constraintsArun Kumar NirmalHaripriya DayalanRohith SGayathri Ayyar
- Nanomaterials as a promising platform for COVID-19Mohammad Hosein Fathian NasabMohammad Amin ManaviMohammad HamrahiFatemeh KhonsariMohaddeseh GelivarisarshariAryan ForoohariMohammad DehghaniSheyda RanjbarFatemeh Atyabi
1.
Nirmal AK, Dayalan H, S R, Ayyar G. Nanoparticles for brain disease: translational failures, blood-brain barrier heterogeneity, and precision design constraints. Precis Nanomed. 2026;9(1):1748-1770. doi:10.33218/001c.157822